Zarnestra (tipifarnib) - Kura Oncology
Menin MLL inhibitors - Kura Oncology
KO-947 - Kura Oncology
http://www.globenewswire.com/news-release/2019/04/30/1812408/0/en/Kura-Oncology-to-Report-First-Quarter-2019-Financial-Results.html
 
Apr 30, 2019
 
Prev Next